We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Silencing Mutated <i>β-Catenin</i> Inhibits Cell Proliferation and Stimulates Apoptosis in the Adrenocortical Cancer Cell Line H295R.
- Authors
Gaujoux, Sébastien; Hantel, Constanze; Launay, Pierre; Bonnet, Stéphane; Perlemoine, Karine; Lefèvre, Lucile; Guillaud-Bataille, Marine; Beuschlein, Felix; Tissier, Frédérique; Bertherat, Jérôme; Rizk-Rabin, Marthe; Ragazzon, Bruno
- Abstract
Context: Adrenocortical carcinoma (ACC) is a rare and highly aggressive endocrine neoplasm, with limited therapeutic options. Activating β-catenin somatic mutations are found in ACC and have been associated with a poor clinical outcome. In fact, activation of the Wnt/β-catenin signaling pathway seems to play a major role in ACC aggressiveness, and might, thus, represent a promising therapeutic target. Objective: Similar to patient tumor specimen the H295 cell line derived from an ACC harbors a natural activating β-catenin mutation. We herein assess the in vitro and in vivo effect of β-catenin inactivation using a doxycyclin (dox) inducible shRNA plasmid in H295R adrenocortical cancer cells line (clone named shβ). Results: Following dox treatment a profound reduction in β-catenin expression was detectable in shβ clones in comparison to control clones (Ctr). Accordingly, we observed a decrease in Wnt/βcatenin-dependent luciferase reporter activity as well as a decreased expression of AXIN2 representing an endogenous β-catenin target gene. Concomitantly, β-catenin silencing resulted in a decreased cell proliferation, cell cycle alterations with cell accumulation in the G1 phase and increased apoptosis in vitro. In vivo, on established tumor xenografts in athymic nude mice, 9 days of β-catenin silencing resulted in a significant reduction of CTNNB1 and AXIN2 expression. Moreover, continous β-catenin silencing, starting 3 days after tumor cell inoculation, was associated with a complete absence of tumor growth in the shβ group while tumors were present in all animals of the control group. Conclusion: In summary, these experiments provide evidences that Wnt/β-catenin pathway inhibition in ACC is a promising therapeutic target.
- Subjects
GENE silencing; CATENINS; INHIBITION of cellular proliferation; APOPTOSIS; ADRENOCORTICAL hormones; CANCER cell culture; ENDOCRINE gland tumors; HEALTH outcome assessment; SOMATIC mutation; TUMOR treatment
- Publication
PLoS ONE, 2013, Vol 8, Issue 2, p1
- ISSN
1932-6203
- Publication type
Article
- DOI
10.1371/journal.pone.0055743